Back to all news
HKU Develops AI-Enabled Optical Device for Rapid, Non-Invasive Cancer Risk Assessment
The University of Hong Kong has introduced a portable AI-enabled optical device for rapid, non-invasive cancer risk detection using saliva samples.
Key Details
- 1Device detects cancer risk through advanced chemical sensing and AI analysis of saliva samples.
- 2Detection process requires under 10 minutes and is designed for ease of use without medical personnel.
- 3Awarded a Gold Medal at the 51st International Exhibition of Inventions of Geneva (2026).
- 4Uses novel luminescent metal complexes that respond to DNA damage, signalling cancer-associated changes.
- 5Preliminary studies showed strong differentiation between healthy and cancer patients (breast and nasopharyngeal carcinoma).
- 6Large-scale clinical validations are underway in collaboration with multiple hospitals.
Why It Matters
This innovation represents a potential shift toward accessible, user-friendly cancer risk screening tools that leverage AI and advanced optical sensing, complementing traditional radiology and pathology workflows. Early, non-invasive detection could enhance monitoring, especially for high-risk populations, and advance integration between molecular diagnostics and digital health.
Source
EurekAlert
Related News
•EurekAlert
NYU AI Model Improves 5-Year Breast Cancer Risk Prediction via 3D Mammograms
NYU researchers developed an AI model using longitudinal 3D mammograms that outperforms single-scan and 2D-based tools in predicting 5-year breast cancer risk.
•EurekAlert
AI Framework Accelerates Aortic Aneurysm Risk Prediction from Imaging
Researchers developed BioPINN-LM, combining physics-informed neural networks and multimodal large language models to deliver fast, interpretable risk assessments for ascending thoracic aortic aneurysms.
•EurekAlert
Study Finds Patient Voices Missing in Generative AI Design for Oncology
A Flinders University-led review found patients and carers are rarely involved in shaping generative AI tools used in oncology.